Pfizer Spinoff Zoetis Takes Pershing Square's Doyle Onto Board
Zoetis, an animal health company spun off from Pfizer in 2013, is taking a representative from Bill Ackman's hedge fund Pershing Square Capital Management onto its board of directors...
Related Articles
- DuPont's Activist Response Has Perfect Formula To Counter Trian's Nelson Peltz also written by Antoine Gara
- Getting Gen-Y on Boards (of Directors) also published in forbes.com
- Family Dollar Sees 'Virtual Certainty' Of Antitrust Clearance For Dollar Tree Merger also written by Antoine Gara
- PepsiCo Puts Trian Business Advisor On Board also categorized in BoardMoves
- Why Do Board Directors And CEOs Need To Value UN Sustainability Goal 5 ? - Achieve Gender Equality And Empower All Women And Girls also categorized in BoardMoves
- Hewlett-Packard Shakes Up Management, Raises Outlook also mentions Management
- Six Years Later, The Problem at HP is Still the Board also published in forbes.com
- D.C. United’s Danita Johnson Becomes First Woman To Join Buzzer’s Board Of Directors also categorized in BoardMoves
- The Future Of Clean Beauty Is Female: Maureen Chiquet, Former Global CEO Of Chanel, Joins Credo Board Of Directors also categorized in BoardMoves
- DuPont Spinoff Fans Flames In Trian Management's Scorched Earth Fight also written by Antoine Gara
Login to comment.